We have data on 53 companies that use OncoMED. The companies using OncoMED are most often found in United States and in the Pharmaceuticals industry. OncoMED is most often used by companies with >10000 employees and >1000M dollars in revenue. Our data for OncoMED usage goes back as far as 3 years and 10 months.
|OncoMed Pharmaceuticals Inc||oncomed.com||United States||50M-100M||50-200|
|Astellas Pharma US, Inc.||astellas.us||United States||>1000M||>10000|
|Lonza Group AG||lonza.com||Switzerland||>1000M||>10000|
|MERCK SHARP & DOHME FEDERAL CREDIT UNION||msdfcu.org||United States||10M-50M||50-200|
We use the best scanning techniques combined with advanced data science to monitor the market share of over 5,000 technology products, including Healthcare. In the Healthcare category, OncoMED has a market share of about 0.1%. Other major and competing products in this category include:
OncoMed Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapeutics that address the fundamental biology driving cancer's growth, resistance, recurrence and metastasis.
Looking at OncoMED customers by industry, we find that Pharmaceuticals (23%), Hospital & Health Care (18%), Financial Services (8%) and Higher Education (8%) are the largest segments.
61% of OncoMED customers are in United States and 6% are in Brazil.